These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 386753)

  • 21. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
    Lammintausta R; Koulu M; Allonen H
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemodynamic advantages of combined alpha-blockade and beta-blockade over beta-blockade alone in patients with coronary heart disease.
    Taylor SH; Silke B; Nelson GI; Okoli RC; Ahuja RC
    Br Med J (Clin Res Ed); 1982 Jul; 285(6338):325-7. PubMed ID: 6807469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension.
    Bahlmann J; Brod J; Hubrich W; Cachovan M; Pretschner P
    Br J Clin Pharmacol; 1979; 8(Suppl 2):113S-117S. PubMed ID: 526390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics, beta-adrenoceptor blockade and anti-hypertensive action of labetalol during chronic oral treatment.
    Sanders GL; Davies DM; Rawlins MD
    Br J Clin Pharmacol; 1980 Aug; 10(2):121-6. PubMed ID: 6252915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental and clinical pharmacology of carvedilol and other drugs combining vasodilation and beta-adrenoceptor antagonism in a single molecule.
    Strein K; Sponer G
    Z Kardiol; 1990; 79 Suppl 3():89-98. PubMed ID: 1983054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Labetalol.
    Carter BL
    Drug Intell Clin Pharm; 1983 Oct; 17(10):704-12. PubMed ID: 6354658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Labetalol: an alpha- and beta-adrenergic receptor blocker.
    Pepper GA
    Nurse Pract; 1985 Jul; 10(7):39-40, 43, 48. PubMed ID: 3855235
    [No Abstract]   [Full Text] [Related]  

  • 28. Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoreceptor blockade by labetalol.
    Koch G
    Br Heart J; 1979 Feb; 41(2):192-8. PubMed ID: 106867
    [No Abstract]   [Full Text] [Related]  

  • 29. Current status of labetalol, the first alpha- and beta-blocking agent.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):617-28. PubMed ID: 2867049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative haemodynamic dose response effects of propranolol and labetalol in coronary heart disease.
    Silke B; Nelson GI; Ahuja RC; Taylor SH
    Br Heart J; 1982 Oct; 48(4):364-71. PubMed ID: 7126388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Labetalol and platelet function in pre-eclampsia.
    Walker JJ; Erwin L; Lang G; Prentice CR; Belch JJ; McLaren M; Forbes CD; Calder AA
    Lancet; 1982 Jul; 2(8292):279. PubMed ID: 6124708
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.
    Richards DA; Tuckman J; Prichard BN
    Br J Clin Pharmacol; 1976 Oct; 3(5):849-55. PubMed ID: 9968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The treatment of hypertension by labetalol--a new alpha- and beta-adrenoreceptor blocking agent.
    Stern N; Teicher A; Rosenthal T
    Clin Cardiol; 1982 Feb; 5(2):125-30. PubMed ID: 7039899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of beta blockers on exercise capacity and on training response in elderly subjects.
    Fagard R; Reybrouck T; Vanhees L; Cattaert A; Vanmeenen T; Grauwels R; Amery A
    Eur Heart J; 1984 Nov; 5 Suppl E():117-20. PubMed ID: 6526030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Contribution to the pharmacology of the beta-adrenolytics].
    Wagner J
    Dtsch Med Wochenschr; 1970 Nov; 95(48):2442-8. PubMed ID: 4394708
    [No Abstract]   [Full Text] [Related]  

  • 36. Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension.
    Lund-Johansen P; Bakke OM
    Br J Clin Pharmacol; 1979 Feb; 7(2):169-74. PubMed ID: 760749
    [No Abstract]   [Full Text] [Related]  

  • 37. [Combined alpha and beta blockade with labetalol. Multicenter general practice study in hypertensive patients with concomitant coronary heart disease].
    Haehn KD; Hotan W; Moerchel J; Müller J
    Fortschr Med; 1987 Sep; 105(27):532-6. PubMed ID: 2824307
    [No Abstract]   [Full Text] [Related]  

  • 38. Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.
    Sanders GL; Murray A; Rawlins MD
    Br J Clin Pharmacol; 1979; 8(Suppl 2):125S-127S. PubMed ID: 43163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immediate effects of labetalol on central, splanchnic-hepatic, and forearm haemodynamics during pleasant emotional stress in hypertensive patients.
    Trap-Jensen J; Clausen JP; Hartling OJ; Svendsen TL; Krogsgaard AR
    Postgrad Med J; 1980; 56 Suppl 2():37-42. PubMed ID: 7433341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchial and cardiac beta-adrenoceptor blockade--a comparison of atenolol, acebutolol and labetalol.
    Gribbin HR; Mackay AD; Baldwin CJ; Tattersfield AE
    Br J Clin Pharmacol; 1981 Jul; 12(1):61-5. PubMed ID: 6264936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.